Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)
Twist Bioscience (TWST)
Foghorn Therapeutics Inc (FHTX)
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
Glaukos Corporation (GKOS)
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance